NCT03997838

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled Trial to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 307 (actual)
• Sponsor: Vivozon, Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following abdominoplasty.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	VVZ-149 Injections	IV infusion of 1000 mg of VVZ-149
DRUG	Placebo	IV infusion of 0 mg of VVZ-149

Timeline

• Start date: 2019-05-23
• Primary completion: 2019-08-03
• Completion: 2019-08-21
• First posted: 2019-06-25
• Last updated: 2020-08-25

Locations

5 sites across 1 country: United States

Regulatory

• FDA-regulated drug study